Keyphrases
Antioxidant
100%
Age-related Changes
100%
Xenobiotics
100%
Nuclear Factor Erythroid 2-like 2
100%
Defense Genes
100%
Protein Expression
42%
Comorbidity
42%
Transcription Factor
28%
Old Age
28%
Adverse Drug Reaction
28%
MRNA Expression
14%
Rodent Models
14%
Cellular Level
14%
Age-related
14%
Novel Therapeutic Targets
14%
Older People
14%
Increasing Age
14%
Quantitative PCR
14%
Enzyme-linked Immunosorbent Assay (ELISA)
14%
Venous Blood
14%
Peripheral Blood Mononuclear Cells
14%
Biological Changes
14%
Age Categories
14%
Polypharmacy
14%
Medicine and Dentistry
Nuclear Factor
100%
Xenobiotic Agent
100%
Antioxidant
100%
Protein Expression
42%
Multiple Chronic Conditions
42%
Senescence
28%
Adverse Drug Reaction
28%
Transcription Factor II
28%
Messenger RNA
28%
Venous Blood
14%
Real-Time Polymerase Chain Reaction
14%
Peripheral Blood Mononuclear Cell
14%
Age Groups
14%
Polypharmacy
14%
Immunology and Microbiology
Protein Expression
100%
Xenobiotic
100%
Senescence
66%
Transcription Factor II
66%
Drug Hypersensitivity
66%
Venous Blood
33%
Real-Time Polymerase Chain Reaction
33%
Peripheral Blood Mononuclear Cell
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antioxidant
100%
Nuclear Factor
100%
Xenobiotic Agent
100%
Multiple Chronic Conditions
42%
Adverse Drug Reaction
28%
Transcription Factor II
28%
Messenger RNA
28%
Polypharmacy
14%
Biochemistry, Genetics and Molecular Biology
Protein Expression
100%
Senescence
66%
Transcription Factor II
66%
Messenger RNA
66%
Enzyme
33%
Real-Time Polymerase Chain Reaction
33%
Peripheral Blood Mononuclear Cell
33%
Neuroscience
Nuclear Factor
100%
Antioxidant
100%
Protein Expression
42%
Transcription Factor II
28%
Senescence
28%
Messenger RNA
28%
Real-Time Polymerase Chain Reaction
14%
Peripheral Blood Mononuclear Cell
14%